CBD Life Sciences Inc.
CBDL · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,549 | $407,062 | $40,706,241 | $12,297,409 |
| - Cash | $7 | $3 | $1 | $1,027 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1,542 | $407,060 | $40,706,241 | $12,296,382 |
| Revenue | $109 | $167 | $160 | $59 |
| % Growth | -34.9% | 4.3% | 170.4% | – |
| Gross Profit | -$10 | -$31 | -$280 | -$148 |
| % Margin | -9.1% | -18.3% | -174.9% | -250.2% |
| EBITDA | -$702 | -$23 | -$806 | -$4,892 |
| % Margin | -644.3% | -13.8% | -503.1% | -8,255% |
| Net Income | -$757 | -$79 | -$860 | -$5,128 |
| % Margin | -695.4% | -47% | -536.6% | -8,654.2% |
| EPS Diluted | -0 | -0.001 | -0 | -0 |
| % Growth | 66.7% | -200% | 50% | – |
| Operating Cash Flow | -$583 | -$17 | -$957 | -$5,148 |
| Capital Expenditures | -$0 | $0 | -$69 | -$162 |
| Free Cash Flow | -$583 | $2 | -$1,026 | -$5,309 |